Recent Research Analysts’ Ratings Updates for Option Care Health (OPCH)

Several brokerages have updated their recommendations and price targets on shares of Option Care Health (NASDAQ: OPCH) in the last few weeks:

• 11/4/2024 – Option Care Health was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $27.00 price target on the stock, down previously from $38.00.
• 11/1/2024 – Option Care Health had its price target lowered by analysts at Truist Financial Co. from $41.00 to $34.00. They now have a “buy” rating on the stock.
• 10/31/2024 – Option Care Health had its price target lowered by analysts at Barrington Research from $40.00 to $32.00. They now have an “outperform” rating on the stock.
• 10/31/2024 – Option Care Health was downgraded by analysts at Jefferies Financial Group Inc. from a “buy” rating to a “hold” rating. They now have a $26.00 price target on the stock, down previously from $38.00.
• 10/30/2024 – Option Care Health was downgraded by analysts at Bank of America Co. from a “buy” rating to a “neutral” rating. They now have a $29.00 price target on the stock, down previously from $43.00.
• 10/23/2024 – Option Care Health had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $40.00 price target on the stock.
• 9/30/2024 – Option Care Health had its price target raised by analysts at JMP Securities from $36.00 to $37.00. They now have a “market outperform” rating on the stock.

Option Care Health Stock Down 0.9 %

OPCH stock opened at $21.74 on Tuesday. Option Care Health, Inc. has a one year low of $21.64 and a one year high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a fifty day moving average of $28.41 and a 200-day moving average of $29.31. The stock has a market capitalization of $3.70 billion, a PE ratio of 18.27, a price-to-earnings-growth ratio of 2.27 and a beta of 1.32.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 8.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OPCH. UMB Bank n.a. raised its holdings in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after acquiring an additional 750 shares during the last quarter. GAMMA Investing LLC raised its stake in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after buying an additional 2,757 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.